Medical Devices – Brazil Regulatory Framework
Brazil represents the biggest market for medical devices in South America. Selling and marketing medical devices in Brazil requires several actions and compliance with legislation and standards, which can be a complex process.

Date

Liliana Teles

Liliana Teles

Regulatory Affairs Manager

GENERAL BRAZILIAN RULES FOR MEDICAL DEVICES

According to the Brazilian National Agency of Health Surveillance (ANVISA), a medical device is “a healthcare product, such as equipment, devices, materials, articles, or systems for medical,  odontological, or laboratory use or application, intended for prevention, diagnosis, treatment, rehabilitation, or anticonception and that does not use pharmacological, immunological, or metabolic means to fulfill its main function in human beings, but can have its functions assisted by such means”.

Medical devices in Brazil must be registered in ANVISA, in accordance with the Brazilian Resolution RDC. No. 185. Manufacturers or importers of such products must submit to ANVISA all the documents required for the registration as well as for its maintenance, revalidation or cancellation. After evaluating all the documentation, ANVISA publishes its decision on the Brazilian Official Gazette (DOU).

The medical device company must be located in Brazil or it will need a licensed third-party company to be the Brazilian registration holder (BRH), which will hold the registration certificate title. Registration of medical devices is valid for 5 years and after that period it may be successively revalidated for the same period.

According to the risk they represent to consumers, patients, users or third parties involved, medical devices are classified as Class I, II, III or IV. In case of doubts in the classification, ANVISA is the one deciding about the classification. Class II devices have a shorter and simplified registration process (known as ‘Cadastro’), whereas Class III and Class IV need to go through a similar path but a little more complex and with some variants (known as ‘Registro’). Medical devices classified as Class III and IV need to be subjected to Brazilian GMP inspections, which are carried out by ANVISA. As an alternative, manufacturers can partake in the Medical Device Single Audit Program (MDSAP). MDSAP audit reports are accepted as a substitute for routine inspections and may be used for medical device registration in ANVISA.  Since May 2019 (RDC 270/2019), Class I medical devices only need a formal notification to ANVISA and do not need to submit to full ‘Cadastro’ approval (registration is not subject to technical review). This 2019 Resolution main goal was to help ANVISA to focus more on high-risk medical products. On the other hand, companies should make sure they have qualified regulatory team so they can ensure compliance with regulations.

The following medical devices are exempt from registration at ANVISA:

  • Medical devices intended for clinical research, when in compliance with legal provisions of the competent health surveillance authority on the performance of this activity, prohibiting such products to be commercialized and used for other purposes.
  • New presentations of a medical device set already registered and in intact individual packaging, provided that its label and instructions for use contain the information about the registration of the corresponding medical devices.
  • Accessories exclusively manufactured to be part of a medical device with a registration whose technical report has information on such accessories.

INMETRO CERTIFICATION

The National Institute of Metrology, Quality and Technology (INMETRO) is the government body responsible for the implementation of measurement, safety and quality standards for electrical and electronic products. This National Institute is in charge of the notification of proposed technical regulations to the World Trade Organization (WTO) and acts as the national enquiry point under the WTO Agreement on Technical Barriers to Trade (TBT). It guides the activities of accreditation, inspection, testing and certification bodies in Brazil. A broad range of products require INMETRO certification accompanied by inspection, including medical devices (electromedical, regardless of their class).

INMETRO certification (conducted in an INMETRO-certified testing laboratory) must be done prior to ANVISA approval, as it is part of the medical product’s technical documentation required for submission. A product that is certified by an INMETRO-accredited Certification Body ensures that such product is compliant with Brazilian regulations and required safety standards. INMETRO certification is valid for 5 years and may be renewed for additional 5.

Placing and marketing a medical device in Brazil market can be a tough task. With an experienced team located both in the EU and Brazil, Critical Catalyst is available to assist your company in any part of the process, making it easier and assuring compliance with the applicable regulatory requirements.

References:

  1. Ministério da Saúde, Agência Nacional de Vigilância Sanitária (ANVISA) – Resolução da Diretoria Colegiada – RDC No. 185, de 22 de Outubro de 2001.
  2. Ministério da Saúde, Agência Nacional de Vigilância Sanitária (ANVISA) – Resolução da Diretoria Colegiada – RDC Nº 27, de 21 de Junho de 2011.
  3. Ministério da Saúde, Agência Nacional de Vigilância Sanitária (ANVISA) – Resolução da Diretoria Colegiada – RDC Nº 270, de 28 de Fevereiro de 2019.
  4. Ministério do Desenvolvimento, Indústria e Comércio Exterior, Instituto Nacional de Metrologia, Normalização e Qualidade Industrial-INMETRO – Portaria nº 350, de 06 de setembro de 2010.

further
reading

medical devices

BREXIT – Impact on Medical Devices placed in the UK market

From 31 of December 2020, the UK will be regarded as a third country and not a Member State of the European Union. There will be some changes regarding medical devices placed in the UK. The UK’s MHRA has published guidance regarding the regulation of medical devices from 1 January 2021, where it explains what changes and what there is to know about placing a medical device in the Great Britain, Northern Ireland and EU markets.

Read More »
medical devices

Brazil – Class II Medical Devices – New Resolution

A new Resolution of the Collegiate Board of Directors (RDC No. 423/2020) has been published by Brazil’s National Agency of Health Surveillance (ANVISA). This new Resolution announces the elimination of the ‘Cadastro’ pathway regarding the registration of medical devices (Class II) and IVDs, substituting it with a notification registration system.

Read More »
cosmetic products

Butylphenyl Methylpropional to be prohibited in cosmetics placed in the EU market

Butylphenyl Methylpropional, also known as Lilial, is a fragrance ingredient that has been used for years in several cosmetic and non-cosmetic products. Nevertheless, some concerns have been expressed regarding the use of this ingredient and its risk to consumers. According to an amendment to the CLP Regulation (Commission Delegated Regulation No. 2020/1182), Butylphenyl Methylpropional is now classified as toxic to reproduction (Repr. 1B – CMR 1B) and it shall be prohibited in cosmetic products from 1st March 2022.

Read More »
cosmetic products

China Bans Microbeads In Cosmetics

On 16th January 2020, China’s National Development and Reform Commission (NDRC) issued the Notice [2020] No. 80, with the aim of prohibiting the use of microbeads in cosmetics and personal care products. More detailed information was given in the Notice [2020] No. 1146, issued by the NDRC on 10th July 2020.

Read More »
medical devices

EU Medical Devices Regulation – Unique Device Identifier (UDI)

In 2017, two Regulations on medical devices (MDR) and in in vitro diagnostic medical devices (IVDR) entered into force in the European Union (EU), establishing a modernized and more robust EU legislative framework and safeguarding a better public health protection and patient safety. According to the these Regulations, the Unique Device Identifier (UDI) will be mandatory for all medical devices and in vitro medical devices.

Read More »
COVID-19

FDA updates on hand sanitizers safety for use

The U.S. Food and Drug Administration (FDA) has announced that it is providing a new laboratory testing method to assess the quality of finished hand sanitizers. Moreover, the FDA has issued a new press release on August 27th 2020, where it warns consumers about hand sanitizers packaged in food and drink containers. Earlier this month, the FDA expanded hand sanitizer warnings to include 1-propanol contamination.

Read More »
cosmetic products

RAPEX System 2019 Report

Every week, the RAPEX system publishes notifications of urgent measures taken by EU Member-States to prevent, restrict or impose conditions on the marketing of products due to the serious and immediate danger they pose to the health and safety of consumers.

Read More »
cosmetic products

Cosmetic Packaging in European Union

Packaging material is defined as the container (or primary packaging) that is in direct contact with the formulation. According to the European Cosmetic Regulation No. 1223/2009, packaging evaluation is mandatory to guarantee cosmetic product safety. To meet this Regulation requirements, the European Commission issued the Decision 2013/674/EU, establishing guidelines on the practical application of such requirements and identifying information that should be collected on the packaging materials and the potential migration of substances from packaging.

Read More »
cosmetic products

“Anti-pollution” claims in cosmetic products

Nowadays, it is possible to find in the market several cosmetic products with claims like “anti-pollution protection”, “pollution shield”, “against pollution damage” and similar ones. But how can a company test and prove this type of allegations?

Read More »
cosmetic products

UK Product Safety and Metrology EU Exit Regulations

The fact that the United Kingdom (UK) has left the European Union (EU) is not news for anyone. This means that the UK will no longer be considered a Member-State of the EU and will be considered a third country, implying that all the EU rules and regulations will no longer apply.

On July 3rd, the UK government has released the last version of the Product Safety and Metrology EU Exit Regulations, which includes the UK Cosmetic Regulation within Schedule 34.

Read More »
COVID-19

Hand sanitizers contaminated with methanol

The new coronavirus SARS-CoV-2 has led to an increasing demand of hand sanitizers. Nevertheless, not all hand sanitizers made available in the market are safe. The U.S. Food and Drug Administration (FDA) has issued a public warning to consumers and health care providers for possible contamination of hand sanitizers with methanol. The FDA advises the public not to use such hand sanitizers, because methanol is a dangerous and toxic substance.

Read More »
cosmetic products

Acetylated Vetiver Oil as a perfuming agent

Acetylated Vetiver Oil, also called Vetiveryl acetate or Vetiveria Zizanioides Root Extract Acetylated, is a natural complex substance derived from Vetiver Oil. In 2019, the European Commission’s Scientific Committee on Consumer Safety (SCCS) issued an opinion on the safety of Acetylated Vetiver Oil in cosmetic products and considered it safe under specific conditions.

Read More »